To: | Novartis AG (mtepper@teiplaw.com) |
Subject: | U.S. Trademark Application Serial No. 88503872 - VERIFY - N/A |
Sent: | July 26, 2019 09:57:31 AM |
Sent As: | ecom108@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88503872
Mark: VERIFY
|
|
Correspondence Address: |
|
Applicant: Novartis AG
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT WITHOUT PRIOR AUTHORIZATION
Issue date: July 26, 2019
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. The trademark examining attorney is amending the application as follows. No prior approval or authorization from applicant or applicant’s attorney is required. TMEP §707.02.
Classification
The application is amended to classify the services in International Class 042. TMEP §1401.03(b); see 37 C.F.R. §2.85.
/Natalie Polzer/
Trademark Examining Attorney
Law Office 108
Phone: (571) 272-4103
natalie.polzer@uspto.gov (not for formal responses)